Epidemiologic study of Langerhans cell histiocytosis in children - 11/09/11
Abstract |
Objective: The etiology and pathogenesis of Langerhans cell histiocytosis (LCH) remain poorly understood. We conducted an exploratory epidemiologic study to investigate potential risk factors associated with LCH.
Study design: We used a case-control study design to obtain data from parents of children with LCH (n=459) who were members of the Histiocytosis Association of America and Canada. The two control groups consisted of 683 community control subjects and 3719 children with chidhood cancers treated at participating Children's Cancer Group institutions.
Results: The median age at diagnosis of LCH was 1.8 years (range 0.1 to 14.6 years). Cases were cetegorized as multisystem LCH (MS-LCH) (n=208) and single-system LCH (SS-LCH) (n=198). Statistically significant associations included the following: infections in the neonatal period (MS-LCH, odds ratio (OR)=2.2), solvent exposure (SS-LCH, OR=54.9), childhood vaccinations (MS-LCH and SS-LCH, OR-0.4), thyroid disease in the proband (MS-LCH and SS-LCH, OR=21.6), and family history of thyroid disease (MS-LCH and SS-LCH, OR=1.4). The association with thyroid disease in the proband was explained partially by the involvement of the pituitary, with the relative risk decreasing when patients with diabetes insipidus and thyroid involvement were excluded from analysis.
Conclusions: This large hypothesis-generating study provides directions for future investigations in well-designed population-based or hospital-based epidemiologic studies.
Le texte complet de cet article est disponible en PDF.Abbreviations : LCH, MS-LCH, SS-LCH
Plan
* | Supported by the Histiocytosis Association of Canada and America, The University of Minnesota Children's Cancer Research Fund, and the Cancer Epidemiology NRSA, National Cancer Institute, National Institutes of Health, Department of Health and Human Serices T32 CA09607. Contributing Children's Cancer Group investigators, institutions, and grant numbers are listed in Appendix 2. |
Vol 130 - N° 5
P. 774-784 - mai 1997 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?